These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 11089517)

  • 1. Impact of migraine and migraine therapy on productivity and quality of life.
    Solomon GD; Santanello N
    Neurology; 2000; 55(9 Suppl 2):S29-35. PubMed ID: 11089517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects on productivity and quality of life of rizatriptan for acute migraine: a workplace study.
    Láinez MJ; López A; Pascual AM
    Headache; 2005; 45(7):883-90. PubMed ID: 15985105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-reported benefits of rizatriptan compared with usual non-triptan therapy for migraine in a primary care setting.
    Baos V; Serrano A; Torrecilla M; Bertral C; Caloto MT; Nocea G; Gerth WC;
    Int J Clin Pract; 2003 Nov; 57(9):761-8. PubMed ID: 14686564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of a worksite migraine intervention program on work productivity, productivity costs, and non-workplace impairment among Spanish postal service employees from an employer perspective.
    Vicente-Herrero T; Burke TA; Laínez MJ
    Curr Med Res Opin; 2004 Nov; 20(11):1805-14. PubMed ID: 15537481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time to pain freedom and onset of pain relief with rizatriptan 10 mg and prescription usual-care oral medications in the acute treatment of migraine headaches: a multicenter, prospective, open-label, two-attack, crossover study.
    Bell CF; Foley KA; Barlas S; Solomon G; Hu XH
    Clin Ther; 2006 Jun; 28(6):872-80. PubMed ID: 16860170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rizatriptan versus usual care in long-term treatment of migraine.
    Silberstein SD
    Neurology; 2000; 55(9 Suppl 2):S25-8. PubMed ID: 11089516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rizatriptan 10-mg wafer versus usual nontriptan therapy for migraine: analysis of return to function and patient preference.
    Pascual J; García-Moncó C; Roig C; Yusta Izquierdo A; López-Gil A;
    Headache; 2005 Oct; 45(9):1140-50. PubMed ID: 16178944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of migraine on patients and their families: the Migraine And Zolmitriptan Evaluation (MAZE) survey--Phase III.
    MacGregor EA; Brandes J; Eikermann A; Giammarco R
    Curr Med Res Opin; 2004 Jul; 20(7):1143-50. PubMed ID: 15265259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life in migraine.
    Mannix LK; Solomon GD
    Clin Neurosci; 1998; 5(1):38-42. PubMed ID: 9523057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Migraine treatment with rizatriptan and non-triptan usual care medications: a pharmacy-based study.
    Cady R; Martin V; Adelman J; Diamond M; Sajjan S; Hu XH
    Headache; 2004 Oct; 44(9):900-7. PubMed ID: 15447699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rizatriptan efficacy in ICHD-II pure menstrual migraine and menstrually related migraine.
    Nett R; Mannix LK; Mueller L; Rodgers A; Hustad CM; Skobieranda F; Ramsey KE
    Headache; 2008 Sep; 48(8):1194-201. PubMed ID: 18422606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of early intervention with almotriptan vs placebo on migraine-associated functional disability: results from the AEGIS Trial.
    Freitag F; Smith T; Mathew N; Rupnow M; Greenberg S; Mao L; Finlayson G; Wright P; Biondi D;
    Headache; 2008 Mar; 48(3):341-54. PubMed ID: 18302700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studies.
    Visser WH; Winner P; Strohmaier K; Klipfel M; Peng Y; McCarroll K; Cady R; Lewis D; Nett R;
    Headache; 2004 Oct; 44(9):891-9. PubMed ID: 15447698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Company reference estimates for productivity loss due to migraine and productivity gains using rizatriptan 10 mg in Germany.
    Yoon MS; Katsarava Z; Liedert B; Krobot KJ; Diener HC; Limmroth V
    Int J Clin Pract; 2006 Mar; 60(3):295-9. PubMed ID: 16494644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term efficacy and tolerability of rizatriptan wafers in migraine.
    Cady R; Crawford G; Ahrens S; Hairwassers D; Getson A; Visser WH; Lines C;
    MedGenMed; 2001 Jun; 3(3):1. PubMed ID: 11549974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the efficacy of migraine therapy.
    Chawluk JB
    Postgrad Med; 2000 Sep; 108(3 Suppl):16-21. PubMed ID: 19667526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sumatriptan treatment for migraine in a health maintenance organization: economic, humanistic, and clinical outcomes.
    Cohen JA; Beall D; Beck A; Rawlings J; Miller DW; Clements B; Pait DG; Batenhorst A
    Clin Ther; 1999 Jan; 21(1):190-204. PubMed ID: 10090435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Satisfaction and recovery of normal activity with rizatriptan 10 mg. Results from the open, prospective, observational 4M study].
    Mateos V; Roig C; López Rodríguez I; López-Gil A
    Neurologia; 2002 Dec; 17(10):621-7. PubMed ID: 12487957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of recent prior opioid use on rizatriptan efficacy. A post hoc pooled analysis.
    Ho TW; Rodgers A; Bigal ME
    Headache; 2009 Mar; 49(3):395-403. PubMed ID: 19222588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of rizatriptan for menstrual migraine in an early intervention model: a prospective subgroup analysis of the rizatriptan TAME (Treat A Migraine Early) studies.
    Martin V; Cady R; Mauskop A; Seidman LS; Rodgers A; Hustad CM; Ramsey KE; Skobieranda F
    Headache; 2008 Feb; 48(2):226-35. PubMed ID: 18005144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.